Pharmaniaga Berhad (7081.KL)
- Previous Close
0.2800 - Open
0.2750 - Bid 0.2600 x --
- Ask 0.2650 x --
- Day's Range
0.2600 - 0.2850 - 52 Week Range
0.2000 - 0.4700 - Volume
2,796,200 - Avg. Volume
2,903,964 - Market Cap (intraday)
381.926M - Beta (5Y Monthly) 1.18
- PE Ratio (TTM)
2.94 - EPS (TTM)
0.0900 - Earnings Date Aug 19, 2025 - Aug 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 8, 2022
- 1y Target Est
0.39
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and installation of medical and hospital equipment. The company also manufactures and sells generic drugs; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and develops pharmacy management system for ordering management system, point-of-sale transactions, and inventory management. The company was founded in 1994 and is based in Shah Alam, Malaysia.
www.pharmaniaga.com3,502
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 7081.KL
View MorePerformance Overview: 7081.KL
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is FTSE Bursa Malaysia KLCI (^KLSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 7081.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 7081.KL
View MoreValuation Measures
Market Cap
381.93M
Enterprise Value
1.40B
Trailing P/E
2.81
Forward P/E
7.79
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.10
Price/Book (mrq)
--
Enterprise Value/Revenue
0.36
Enterprise Value/EBITDA
5.13
Financial Highlights
Profitability and Income Statement
Profit Margin
3.53%
Return on Assets (ttm)
7.91%
Return on Equity (ttm)
--
Revenue (ttm)
3.85B
Net Income Avi to Common (ttm)
135.76M
Diluted EPS (ttm)
0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
138.19M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
85.92M